Article
ADME pathway approach for pharmacogenetic studies of anti-HIV therapy.
Pharmacogenomics - 1 Jun 2007
Lubomirov Rubin, Csajka Chantal, Telenti Amalio
Abstract excerpt
Pharmacogenetics holds promise in HIV treatment because of the complexity and potential toxicity of multidrug therapies that are prescribed for long periods. However, there has been limited success with the current approach where one or few candidate genes are examined for a limited number of allelic variants. A change in paradigm emerges from the availability of the HapMap, the wealth of data on less common...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
